| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |